Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
Nov 20 ADVM Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 20 VYGR Voyager selects gene therapy development candidate for Alzheimer’s disease
Nov 20 LXEO Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation
Nov 20 VYGR Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Nov 19 NGNE Neurogene GAAP EPS of -$1.19 in-line
Nov 18 NGNE Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates
Nov 18 NGNE How A Side Effect Has Wiped Out 73% Of Neurogene's Value In A Week
Nov 18 ADVM Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients
Nov 18 VYGR Voyager Therapeutics' Tracer Platform Targets CNS Market: Here's Why I'm Neutral
Nov 18 NGNE Neurogene stock plunges 36% on NGN-401 study update
Nov 18 ADVM Adverum Reports Positive Ixo-vec Data for Wet Age-Related Macular Degeneration; Shares Rise Pre-Bell
Nov 18 ADVM Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
Nov 18 NGNE Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
Nov 15 ADVM Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
Nov 15 NGNE Earnings Scheduled For November 15, 2024
Nov 15 GUTS Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags